Skip to content
  • Home
  • Bio
  • Infographics
  • Patent Applications
  • Publications
  • Surveys
  • Contact
  • Consulting Website
  • LinkedIn Profile
  • Twitter

Biomarkers, Diagnostics, and More

Diagnostics, Life Science, and Biotechnology Consulting for Investors, CEOs, and Functional | Department Heads

Barriers to Personalized Medicine and Companion Diagnostics

companion-diagnostic-101016

Share this:

  • Print
  • Email
  • Twitter
  • LinkedIn
  • Facebook
  • Pinterest
  • More
  • Reddit

Like this:

Like Loading...

Related

October 11, 2016 Winton GibbonsBiomarkers, Disease Management, Health Economics, Product development, Strategy, UncategorizedProduct Management, Public health

Post navigation

Previous Post FDA: All Donated Blood in U.S. Should Be Tested for Zika – from NYT
Next Post Perspectives (update)

Blog Stats

  • 20,228 hits

Contact Form

 Please provide contact information (optional)
(check if yes)

Follow me on Twitter

My Tweets

Winton quoted by

Biocentury, Bloomberg and Bloomberg TV, Boston Herald, CBS Market Watch, Chicago Tribune, CNBC TV, Dow Jones, Forbes, In Vivo, Investor’s Business Daily, MSNBC TV, Nature, New York Times, PBS, Reuters, San Francisco Chronicle, SmartMoney.com, TheStreet.com, USA Today, Wall Street Journal, Washington Post.

Recent Posts

  • Performing Marketing Assessments for Medical Products
  • Approach to Product | Market “Triangulation”
  • Business Development Compass™
  • Perspectives (update)
  • Barriers to Personalized Medicine and Companion Diagnostics
  • FDA: All Donated Blood in U.S. Should Be Tested for Zika – from NYT
  • Siloam Biosciences Optimiser™ Plus Microfluidics for Life Science and Diagnostic Assays – Just a Drop of Blood for Multiple Tests
  • Selling a Pre-commercial Diagnostic or Life Science Company

Search archives by month

Search by category

Enter your email address to follow this blog and receive notifications of new posts by email.

RSS Feed RSS - Posts

Get your family vaccinated. FightFlu

Winton Gibbons

Diagnostics, Life Science, and Biotechnology Consulting for Investors, CEOs, and Functional | Department Heads.

Expertise is in strategy, corporate and business development, marketing and financial assessments, and innovation.

I provide sophisticated quantitative and qualitative analysis, backing strategically sound scenarios and recommendations. This is based on deep real-world experience, and an ability to quickly assess technologies and markets. I have a knack for cutting through complex problems with specific, fact-based solutions.

Website Built with WordPress.com.
  • Follow Following
    • Biomarkers, Diagnostics, and More
      • Join 32 other followers
    • Already have a WordPress.com account? Log in now.
    • Biomarkers, Diagnostics, and More
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...
 

    %d bloggers like this: